NTRK1 and female reproductive organ cancer: HER2, an oncogenic receptor tyrosine kinase, is frequently amplified or overactivated in various solid tumors, including breast, gastric, biliary tract, bladder, pulmonary, and gynecological cancers (Najjar et al., 2022).